semaglutide vision loss Injectable weight drugs linked to rare loss A new study published in

Users apply one patch daily to clean, dry skin on areas like the arm, abdomen, or thigh, allowing for steady absorption that avoids gastrointestinal upset.Formulated with natural compounds that promote endogenous GLP-1 production, LifeGauge avoids synthetic hormones, positioning it as a supportive tool rather than a direct medication replacement

Women who may be well-suited for tirzepatide-based treatment include those who: Have a BMI of 27 or higher with a weight-related health condition or a BMI of 30 or higher

Together, they create a more comprehensive effect than either achieves alone

Copyright 2026

A recent multicenter international phase II RCT (GOLDEN-505) in noncirrhotic biopsy-proven NASH patients showed an insignificant difference in NASH resolution without fibrosis progression between the elafibranor and placebo groups at 52 weeks of treatment